ASHLEY LEDSON: Open Payments
NPI 1902465271 · WILLIAMSON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 93 payments from 20 companies in 2025. Trend: 2023 $2,558 · 2024 $2,312 · 2025 $1,562
Food & beverage: $1,562
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 36 | $397 |
| AstraZeneca Pharmaceuticals LP | 7 | $172 |
| Viatris Specialty LLC | 5 | $154 |
| Verona Pharma, Inc. | 10 | $142 |
| Genentech USA, Inc. | 7 | $127 |
| GENZYME CORPORATION | 4 | $105 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Inspire Medical Systems, Inc. | 3 | $61 |
| United Therapeutics Corporation | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
Products named: NUCALA, TRELEGY ELLIPTA, YUPELRI, Ohtuvayre, Xolair, DUPIXENT, BREZTRI, Sunosi.
Industry payments across WV — which companies pay providers there.
